Ischemia-modified Albumin Determination Kit (Albumin-Cobalt Binding Method) - NMPA Registration 吉械注准20242400361
Access comprehensive regulatory information for Ischemia-modified Albumin Determination Kit (Albumin-Cobalt Binding Method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 吉械注准20242400361 and owned by Jilin Base Egg Biological Technology Co., Ltd.. The device was approved on July 16, 2024.
This page provides complete registration details including registrant information, province location (Jilin), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
It is used for in vitro quantitative determination of ischemic modified albumin content in human serum and plasma.
用于体外定量测定人血清、血浆中缺血修饰白蛋白的含量。
Reagent 1 (R1): Cobalt chloride 10mmol/L. Reagent 2 (R2): dithiothreitol 200mmol/L. Calibrator (optional): Bovine serum albumin, see label for specific concentrations. Control (optional): Bovine serum albumin, see label for specific concentrations.
试剂1(R1):氯化钴 10mmol/L。 试剂2(R2):二硫苏糖醇 200mmol/L。 校准品(可选配):牛血清白蛋白,具体浓度详见标签。 质控品(可选配):牛血清白蛋白,具体浓度详见标签。

